Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 31: 1931-1935, 1985;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hicks, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hicks, J. M.

Clinical Chemistry, Vol 31, 1931-1935, Copyright © 1985 by American Association for Clinical Chemistry

In situ monitoring

JM Hicks

In situ monitoring has been increasingly accepted during the past five years. This approach has been applied to measurement of gas tensions such as pO2 and pCO2, to pH and ions, to the assessment of jaundice by measurement of bilirubin, and to analysis for 14CO2 after administration of labeled antipyrine and aminopyrine, for evaluation of hepatic damage. Various techniques have been developed for in situ monitoring: transcutaneous measurements, implantable sensors, ingestible radio-sensitive pills, and breath analysis. Here I review some of these approaches and their limitations. These limitations include the sparsity of circumstances under which the technique can be applied and the probable increase in health-care costs.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the American Association for Clinical Chemistry.